United-Guardian, Inc.

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: US9105711082
USD
5.94
0.17 (2.95%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About United-Guardian, Inc. stock-summary
stock-summary
United-Guardian, Inc.
Specialty Chemicals
United-Guardian, Inc. manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, healthcare products and specialty industrial products. The Company also conducts research and product development, primarily related to the development of cosmetic and personal care products. Its research and development department also modifies, refines, and expands the uses for existing products. Its products are separated into approximately four distinct product categories, such as personal care products (including cosmetic ingredients), pharmaceuticals, medical products and industrial products. Its personal care products are marketed globally by approximately six marketing partners. The products are sold directly to marketing partners, which in turn resell those products to its customers for use in the manufacture or compounding of the customers' personal care and cosmetic products.
Company Coordinates stock-summary
Company Details
230 Marcus Blvd , HAUPPAUGE NY : 11788-3731
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 8 Schemes (10.15%)

Foreign Institutions

Held by 6 Foreign Institutions (0.59%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Kenneth Globus
Chairman of the Board, President, Chief Executive Officer, General Counsel
Mr. Andrew Boccone
Independent Director
Mr. Arthur Dresner
Independent Director
Mr. Lawrence Maietta
Independent Director
Mr. S. Ari Papoulias
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
3 Million
(Quarterly Results - Jun 2025)
Net Profit:
1 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 39 Million (Micro Cap)

stock-summary
P/E

13.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

7.10%

stock-summary
Debt Equity

-0.73

stock-summary
Return on Equity

22.07%

stock-summary
Price to Book

3.39